Logo image of TRIB

TRINITY BIOTECH PLC-SPON ADR (TRIB) Stock Price, Quote, News and Overview

NASDAQ:TRIB - Nasdaq - US8964385046 - ADR - Currency: USD

0.693  -0.05 (-6.35%)

After market: 0.69 0 (-0.43%)

TRIB Quote, Performance and Key Statistics

TRINITY BIOTECH PLC-SPON ADR

NASDAQ:TRIB (5/23/2025, 8:59:56 PM)

After market: 0.69 0 (-0.43%)

0.693

-0.05 (-6.35%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High3.55
52 Week Low0.48
Market Cap13.30M
Shares19.19M
Float4.22M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-13 2025-08-13/bmo
IPO10-21 1992-10-21


TRIB short term performance overview.The bars show the price performance of TRIB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

TRIB long term performance overview.The bars show the price performance of TRIB in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of TRIB is 0.693 USD. In the past month the price decreased by -2.12%. In the past year, price decreased by -58.99%.

TRINITY BIOTECH PLC-SPON ADR / TRIB Daily stock chart

TRIB Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.47 228.44B
ISRG INTUITIVE SURGICAL INC 70.62 193.38B
BSX BOSTON SCIENTIFIC CORP 38.7 154.60B
SYK STRYKER CORP 30.06 143.93B
MDT MEDTRONIC PLC 14.67 103.48B
BDX BECTON DICKINSON AND CO 12.16 49.12B
EW EDWARDS LIFESCIENCES CORP 28.84 44.09B
IDXX IDEXX LABORATORIES INC 44 40.65B
RMD RESMED INC 26.74 35.61B
DXCM DEXCOM INC 51.22 33.14B
GEHC GE HEALTHCARE TECHNOLOGY 15.03 31.66B
STE STERIS PLC 26.02 23.87B

About TRIB

Company Profile

TRIB logo image Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The firm is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The firm develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. The company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company, through EpiCapture Limited, is also developing a non-invasive test for monitoring the risk of aggressive prostate cancer. The firm sells its products direct in the United States and through a network of international distributors.

Company Info

TRINITY BIOTECH PLC-SPON ADR

Ida Business Park, Bray, Co Wicklow

DUBLIN WICKLOW IE

CEO: Ronan O'Caoimh

Employees: 380

TRIB Company Website

TRIB Investor Relations

Phone: 1135312955111

TRINITY BIOTECH PLC-SPON ADR / TRIB FAQ

What is the stock price of TRINITY BIOTECH PLC-SPON ADR today?

The current stock price of TRIB is 0.693 USD. The price decreased by -6.35% in the last trading session.


What is the ticker symbol for TRINITY BIOTECH PLC-SPON ADR stock?

The exchange symbol of TRINITY BIOTECH PLC-SPON ADR is TRIB and it is listed on the Nasdaq exchange.


On which exchange is TRIB stock listed?

TRIB stock is listed on the Nasdaq exchange.


What is TRINITY BIOTECH PLC-SPON ADR worth?

TRINITY BIOTECH PLC-SPON ADR (TRIB) has a market capitalization of 13.30M USD. This makes TRIB a Nano Cap stock.


How many employees does TRINITY BIOTECH PLC-SPON ADR have?

TRINITY BIOTECH PLC-SPON ADR (TRIB) currently has 380 employees.


What are the support and resistance levels for TRINITY BIOTECH PLC-SPON ADR (TRIB) stock?

TRINITY BIOTECH PLC-SPON ADR (TRIB) has a support level at 0.68 and a resistance level at 0.8. Check the full technical report for a detailed analysis of TRIB support and resistance levels.


Is TRINITY BIOTECH PLC-SPON ADR (TRIB) expected to grow?

The Revenue of TRINITY BIOTECH PLC-SPON ADR (TRIB) is expected to grow by 10.13% in the next year. Check the estimates tab for more information on the TRIB EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy TRINITY BIOTECH PLC-SPON ADR (TRIB) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does TRINITY BIOTECH PLC-SPON ADR (TRIB) stock pay dividends?

TRIB does not pay a dividend.


When does TRINITY BIOTECH PLC-SPON ADR (TRIB) report earnings?

TRINITY BIOTECH PLC-SPON ADR (TRIB) will report earnings on 2025-08-13, before the market open.


What is the Price/Earnings (PE) ratio of TRINITY BIOTECH PLC-SPON ADR (TRIB)?

TRINITY BIOTECH PLC-SPON ADR (TRIB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.68).


What is the Short Interest ratio of TRINITY BIOTECH PLC-SPON ADR (TRIB) stock?

The outstanding short interest for TRINITY BIOTECH PLC-SPON ADR (TRIB) is 2.8% of its float. Check the ownership tab for more information on the TRIB short interest.


TRIB Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to TRIB. When comparing the yearly performance of all stocks, TRIB is a bad performer in the overall market: 88.44% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

TRIB Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to TRIB. TRIB may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TRIB Financial Highlights

Over the last trailing twelve months TRIB reported a non-GAAP Earnings per Share(EPS) of -2.68.


Industry RankSector Rank
PM (TTM) N/A
ROA -20.87%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%18.09%
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

TRIB Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 86% to TRIB. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 65.8% and a revenue growth 10.13% for TRIB


Ownership
Inst Owners4.63%
Ins OwnersN/A
Short Float %2.8%
Short Ratio1.98
Analysts
Analysts85.71
Price TargetN/A
EPS Next Y65.8%
Revenue Next Year10.13%